Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study

Q2 Medicine

The Journal of rheumatology. Supplement Pub Date : 2022-03-15 DOI:10.3899/jrheum.211156

L. Amezcua-Guerra, M. Mora-Ramírez, G. Vancini, V. Jiménez-Rojas, R. Márquez-Velasco

引用次数: 0

Abstract

Systemic sclerosis (SSc) is a devastating disease associated with lung involvement, primarily interstitial lung disease (ILD) and pulmonary hypertension (PH).1 Although computed tomography (CT) and right heart catheterization accurately identify cardiopulmonary injury,2 their high cost and technical complexity make them inaccessible to most nonspecialized health centers. Thus, the timely detection of lung involvement remains a challenge in real-world settings.

查看原文本刊更多论文

成纤维细胞生长因子23水平与系统性硬化症相关的肺受累:一项概念验证研究

系统性硬化症(SSc)是一种与肺受累相关的毁灭性疾病，主要是间质性肺疾病(ILD)和肺动脉高压(PH)虽然计算机断层扫描(CT)和右心导管可以准确地识别心肺损伤，但它们的高成本和技术复杂性使大多数非专业医疗中心无法使用。因此，在现实世界中，及时发现肺部受累仍然是一个挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Journal of rheumatology. Supplement Medicine-Medicine (all)

自引率

0.00%

发文量

期刊介绍： The Journal of Rheumatology is a monthly international serial edited by Duncan A. Gordon, The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 36 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.